Trial Identifier: | D3250R00113 |
Sponsor: | AstraZeneca |
Start Date: | February 2023 |
Primary Completion Date: | April 2025 |
Study Completion Date: | April 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Colombia | Bogota, Colombia |
Colombia | Bucaramanga, Colombia |
Colombia | Ibague, Colombia |
Colombia | Pereira, Colombia |
Dominican Republic | Santiago, Dominican Republic |
Dominican Republic | Santo Domingo, Dominican Republic |
India | Ahmedabad, India |
India | Ajmer, India |
India | Chennai, India |
India | Delhi, India |
India | Hyderabad, India |
India | Jaipur, India |
India | Kolkata, India |
India | Pune, India |
India | Secundrabad, India |
India | Vadodara, India |
Kuwait | Sabah Al Salem, Kuwait |
Oman | Muscat, Oman |
Qatar | Doha, Qatar |
Saudi Arabia | Jeddah, Saudi Arabia |
Saudi Arabia | Riyadh, Saudi Arabia |
United Arab Emirates | Abu Dhabi, United Arab Emirates |
United Arab Emirates | Al Ain, United Arab Emirates |
United Arab Emirates | Dubai, United Arab Emirates |